Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $294.5 million versus the consensus estimate of $284.31 million.

Acadia Healthcare sees FY2014 EPS of $1.52-$1.53, versus prior guidance of $1.44-$1.46 and the consensus of $1.46.

The company announced a definitive agreement for the acquisition of CRC Health Group Inc., the nation’s largest specialized behavioral healthcare provider. CRC, headquartered in Cupertino, California, provides substance abuse treatment and other specialty programs through 36 residential facilities and 84 comprehensive treatment facilities that currently treat approximately 40,000 patients daily. These facilities are expected to produce aggregate revenues for 2014 of approximately $450 million and adjusted EBITDA of approximately $115 million. Consideration for the acquisition of privately held CRC is $1.175 billion, consisting of up to approximately 6.3 million shares of Acadia’s common stock and the assumption of CRC’s debt. We expect to complete this accretive transaction, which is subject to normal closing conditions, in the first quarter of 2015.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.